Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

During the Trading Day
51.49 +0.36 / +0.70%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
51.74 +0.25 / +0.49%
 
Volume: 282.2K

Today’s Trading

Previous close51.13
Today’s open51.52
Day’s range50.42 - 52.93
Volume8,263,107
Average volume (3 months)7,076,744
Market cap$25.1B
Dividend yield--
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+18.03%
Earnings growth (next 5 years)+10.65%
Revenue growth (last year)+12.42%
P/E ratio22.2
Price/Sales2.89
Price/Book5.89

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+4.43+2.41%
ZTSZoetis Inc+1.61+3.64%
BMRNBiomarin Pharmaceuti...+2.79+2.18%
INCYIncyte Corp+5.36+4.94%
Data as of 4:04pm ET, 08/27/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)$1.35
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

Partner Offers